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Methylenedioxypyrovalerone (MDPV) is generally considered to be a more potent
cocaine-like psychostimulant, as it shares a similar pharmacological profile with cocaine
and induces similar physiological and locomotor responses. Recently, we showed
that intravenous cocaine induces rapid rise in nucleus accumbens (NAc) glucose and
established its relation to neural activation triggered by the peripheral drug actions.
This study was conducted to find out whether MDPV, at a behaviorally equivalent
dose, shares a similar pattern of NAc glucose dynamics. Using enzyme-based glucose
sensors coupled with amperometery in freely moving rats, we found that MDPV tonically
decreases NAc glucose levels, a response that is opposite to what we previously
observed with cocaine. By analyzing Skin-Muscle temperature differentials, a valid
measure of skin vascular tone, we found that MDPV induces vasoconstriction; a similar
effect at the level of cerebral vessels could be responsible for the MDPV-induced
decrease in NAc glucose. While cocaine also induced comparable, if not slightly
stronger peripheral vasoconstriction, this effect was overpowered by local neural
activity-induced vasodilation, resulting in rapid surge in NAc glucose. These results imply
that cocaine-users may be more susceptible to addiction than MDPV-users due to the
presence of an interoceptive signal (i.e., sensory cue), which may result in earlier and
more direct reward detection. Additionally, while health complications arising from acute
cocaine use are typically cardiovascular related, MDPV may be more dangerous to the
brain due to uncompensated cerebral vasoconstriction.
Keywords: electrochemistry and electrochemical processes, brain thermorecording, extracellular glucose
concentration, vascular tone, metabolism

Introduction
Methylenedioxypyrovalerone (MDPV) is a new psychoactive drug of abuse that has recently
gained popularity with the emergence of “bath salts” (Baumann et al., 2013; Iversen et al., 2014;
Watterson et al., 2014). MDPV is often considered a cocaine-like drug as its primary effects are
mediated via an interaction with the same monoamine transporters as cocaine, resulting in similar
physiological and locomotor effects (Ross et al., 2012; Baumann et al., 2013; Gregg and Rawls,
2014). However, while cocaine has relatively equal affinities with all the monoamine transporters,
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MDPV shows differing affinities. Specifically, MDPV is
exceptionally potent at the dopamine (DA) transporter and
shows a lower affinity at the norepinephrine transporter, while
being virtually ineffective at the serotonin transporter (Baumann
et al., 2013). These differences may account for the higher
potency of MDPV compared to cocaine (∼10x) as well as the
distinct behavioral, physiological, and psycho-emotional effects
of these drugs (Fantegrossi et al., 2013; Watterson et al., 2014;
Aarde et al., 2015). Although humans typically orally consume
MDPV, rats intravenously (iv) self-administer this drug at
rates comparable to cocaine (Aarde et al., 2013, 2015; Bonano
et al., 2014; Watterson et al., 2014), indicating a high addictive
potential and, in light of MDPV’s low cost and much higher
potency, a high probability for significant health complications
during drug overdose.
Recently, we showed that iv cocaine induces biphasic increases
in nucleus accumbens (NAc) glucose levels, characterized by
a first, rapid phase that remains stable following repeated
drug injections and a second tonic phase that diminishes
following repeated injections (Wakabayashi and Kiyatkin,
2015a). Although it is known that cocaine induces peripheral
vasoconstriction (Knuepfer and Branch, 1992; Brown and
Kiyatkin, 2005), a similar effect on the cerebral vessels should
result in a decrease, rather than a rapid surge in glucose.
Therefore, we hypothesized that cocaine-induced systemic
vasoconstriction is superseded by drug-induced local neuronal
activity-dependent vasodilation, triggered by rapid, transient
excitation of accumbal neurons (Kiyatkin and Brown, 2007).
Although these rapid central effects occurring within the
injection are often attributed to the direct actions of cocaine in
the brain, they are in fact mediated via a peripherally triggered
mechanism. Previously, we showed that cocaine-methiodide,
a cocaine analog that cannot cross the blood-brain barrier,
induces many of the same ultra-fast responses as cocaine itself,
including skin vasoconstriction (Brown and Kiyatkin, 2005),
cortical EEG desynchronization (Kiyatkin and Smirnov, 2010),
excitation of accumbal neurons (Kiyatkin and Brown, 2007), and
a rapid rise in NAc glucose (Wakabayashi and Kiyatkin, 2015a).
Therefore, by stimulating peripheral sensory afferents, iv cocaine
induces a neural signal that is rapidly transmitted to the CNS,
resulting in neural activation, local neural activity-dependent
vasodilation, and enhanced entry of glucose and oxygen into
the brain’s extracellular space. Due to this peripheral action,
cocaine administration produces its own sensory cue which may
result in earlier and more direct reward signaling, that could be
important for the acquisition of drug-taking behaviors (see Wise
and Kiyatkin, 2011 for review).
MDPV, like cocaine, induces metabolic brain activation
and peripheral vasoconstriction (Kiyatkin et al., 2015), two
determinants of extracellular glucose levels (Kiyatkin et al., 2013).
As there is very limited knowledge regarding the neurochemical
and metabolic effects of MDPV, this study was designed to
evaluate whether MDPV shares a similar pattern of NAc
glucose dynamics with cocaine. Such data could provide valuable
information not only on possible contributions of the peripheral
and central actions of this drug on metabolic neural responses,
but also may have implications regarding the addiction liability
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of MDPV. Here, enzyme-based glucose sensors coupled with
constant-potential amperometery were used in freely moving
rats to examine NAc glucose changes induced by MDPV
administered iv at a dose optimal for drug self-administration
(0.1 mg/kg). These changes were compared to those induced by iv
cocaine injected at an optimal self-administering dose (1 mg/kg).
Cocaine-induced changes in NAc glucose were described in detail
previously (Wakabayashi and Kiyatkin, 2015a); here they were
re-analyzed and shown to contrast them to changes induced by
MDPV at a behaviorally equipotential dose. To mimic human
conditions where these drugs are repeatedly used in a relatively
short time frame, we examined the effects of four repeated
injections of MDPV and cocaine during 1 day-long recording
session.
Our electrochemical recordings were supplemented by direct
monitoring of temperatures in the NAc, temporal muscle and
skin and locomotor activity. This three-point thermorecording
paradigm allowed us to compare the effects of each drug on
intra-brain heat accumulation due to metabolic activation and
peripheral vascular tone (Kiyatkin, 2010). Using this two-level
analysis, we were able to parse the mechanisms underlying
distinct patterns in NAc glucose induced by MDPV and cocaine,
as well as the within-session changes in these patterns following
repeated drug administration.

Materials and Methods
Animals and Housing
Twenty-two male Long-Evans rats (440 ± 20 g at the time of
surgery) supplied by Charles River Laboratories (Greensboro,
NC) were housed individually in a temperature-, humidity-, and
light-controlled room (12/12 h light/dark cycle, lights on at 07:00)
with free access to food and water. Protocols were performed in
compliance with the Guide for the Care and Use of Laboratory
Animals (NIH, Publication 865-23) and were approved by the
NIDA-IRP Animal Care and Use Committee.

General Structure of the Study
This study combines the results of two experiments. In
Experiment I (n = 11 rats), we examined the changes in
NAc extracellular glucose levels induced by iv injections of
MDPV in freely moving rats during a single, day-long session.
For comparison, we analyzed these results with respect to
changes induced by iv cocaine administered using an identical
experimental protocol (see Wakabayashi and Kiyatkin, 2015a).
Rats were surgically prepared for electrochemical recordings
(see below) that were conducted during one daily session.
In Experiment II (n = 8 rats), using the same in-session
protocol as in Experiment I, we examined the effects of MDPV
or cocaine on NAc, temporal muscle, and skin temperatures.
Rats for this experiment were surgically implanted with chronic
thermocouple sensors. In a counterbalanced design, MDPV and
cocaine were administered to well-habituated rats during two
interleaved sessions such that each rat received both drugs. The
use of both within- and between-animal comparisons allowed
us to minimize the number of rats with chronic implants and
increase statistical strength of our findings.
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Common Procedures in Both Experiments

oxidation current generated by a +0.6 V applied potential (Hu
and Wilson, 1997). The potential contribution of ascorbic acid to
the measured current is competitively reduced by co-localizing
ascorbic acid oxidase enzymes on the active surface of the
sensor. This enzyme converts ascorbic acid to non-electroactive
dehydroascorbate and water. In addition, a negatively charged
Nafion polymer layer under the enzyme layer serves to exclude
endogenous anionic compounds (Hu and Wilson, 1997).
Glucose sensors were calibrated immediately before and after
each in vivo experiment. In vitro calibrations were conducted
in PBS (pH 7.4) by incrementally increasing the concentration
of glucose (Sigma-Aldrich) from 0 to 0.5, 1.0, and 1.5 mM
followed by a single addition of ascorbate (25 µM). Within this
physiological range of glucose levels (Fellows and Boutelle, 1993;
McNay et al., 2001), glucose sensors used in this study produced
incremental linear current increases. Mean sensitivity to glucose
was 2.82 ± 0.22 nA/0.5 nM at 22–23◦ C and 5.51 nA at 37◦ C.
Glucose sensors showed low sensitivity to ascorbate (0.06 ± 0.04
nA/25 µM at 22–23◦ C) and, as shown previously, they were only
minimally sensitive to dopamine at its physiological levels (5–
50 pA/10–100 nM). Glucose sensors remained equally sensitive
to glucose and selective against ascorbate during post-recording
in vitro calibrations (2.57 ± 0.16 nA/0.5 mM and 0.24 nA ±
0.12/25 µM, respectively). Since our previous in vitro and in vivo
tests revealed the importance of control recordings with glucosenull sensors for reliable detection of glucose (Kiyatkin and
Wakabayashi, 2015), in addition to experiments with a glucoseactive sensors (n = 8), similar experiments with glucose-null
sensors were conducted on another group of rats (n = 4).

In both experiments, rats were implanted with a chronic jugular
catheter, which ran subcutaneously to a head mount constructed
specifically for either experiment (see below), made from dental
acrylic and secured to the skull by three stainless steel bone
screws. Rats were allowed a minimum of 4 days of postoperative recovery; jugular catheters were flushed daily with
0.2 ml heparinized saline (10 units/ml) to maintain patency. At
the onset of both experiments, the injection port of the jugular
catheter on the head mount was connected to plastic catheter
extensions that allowed stress- and cue-free delivery of saline
and the tested substance from outside the cage, thus minimizing
possible detection of the iv drug injection by the rat.
All rats underwent similar habituation to the testing
environment (a minimum of 6 h a day for 3 consecutive days)
prior to testing. Similarly, cages for both experiments were
equipped with four infrared motion detectors (Med Associates)
to measure locomotor activity. On test day, experiments always
began 5 days after surgery and were conducted during the lightphase of the cycle (10:00–17:00).

Experiment I
Surgical Preparations
Each rat used was surgically prepared for electrochemical
recordings as described in detail previously (Kiyatkin and Lenoir,
2012; Wakabayashi and Kiyatkin, 2014, 2015a,b). Briefly, under
general anesthesia (Equithesin 0.33 ml/100 g, ip), rats were
implanted with a BASi cannula (Bioanalytical Systems, Inc.;
West Lafayette, IN) for future insertions of a biosensor in the
medial sector of the nucleus accumbens (NAc shell). The target
coordinates were: AP +1.2 mm, ML ±0.8 mm, and DV 7.3 mm,
according to the stereotaxic atlas of Paxinos and Watson (Paxinos
and Watson, 1997). The guide cannula hub was fixed to the
skull with a head mount constructed from dental acrylic that
was secured using three stainless steel bone screws. During the
same surgical procedure, rats were also implanted with a chronic
jugular catheter, as described above.

Protocol
In the electrochemical experiment (n = 11 rats), we examined
changes in NAc extracellular glucose levels ([glucose]) induced
by iv injections of MDPV. Electrochemical recordings occurred
in an electrically insulated chamber (38 × 47 × 47 cm) under
continuous dim illumination (20 W red light bulb), with a room
wide air filter fan providing background noise.
At the beginning of each experimental session, rats were
minimally anesthetized (<2 min) with isoflurane and a calibrated
glucose sensor was inserted into the brain through the
guide cannula. The sensor was connected to the potentiostat
(Model 3104, Pinnacle Technology) via an electrically shielded
flexible cable and a multi-channel electrical swivel. Testing
began ∼140 min after insertion of the sensor when the baseline
currents relatively stabilized and continued for 3–5 h.
Experiments with MDPV and cocaine had identical protocols
that differed only by the drug. In both experiments, we used null
sensors. Each rat received one saline injection (0.2 ml delivered
over 20 s) and four injections of either MDPV (0.1 mg/kg
dissolved in 0.2 ml saline and delivered over 20 s) or cocaine
(1 mg/kg dissolved in 0.2 ml saline and delivered over 20 s).
Intervals between drug injections were 60 min for both drugs.
This time interval greatly exceeds the half-life of iv cocaine
(Tsibulsky and Norman, 1999) and is sufficient for restoring both
physiological and behavioral effects of cocaine at the low dose
used in this study (Brown and Kiyatkin, 2005). At the end of each
session, rats were iv injected with Equithesin (0.8 ml delivered

Fixed-potential Amperometry with Enzyme-based
Glucose Sensors
Commercially produced glucose oxidase-based biosensors
(Pinnacle Technology, Inc.) coupled with fixed-potential
amperometry have been extensively used in our previous studies
(Kiyatkin and Lenoir, 2012; Kiyatkin et al., 2013; Kiyatkin
and Wakabayashi, 2015; Wakabayashi and Kiyatkin, 2015a,b).
These reports describe in detail multiple issues regarding the
sensitivity/selectivity of these sensors, their in vitro and in vivo
performance, and possible physical and chemical contributions
that could be evaluated and controlled for providing high
reliability and accuracy of electrochemical measurements of
extracellular glucose fluctuations.
Briefly, glucose sensors are prepared from Pt-Ir wire of
180 µm diameter, with a sensing cavity of ∼1 mm length on
its tip. The active electrode is incorporated with an integrated
Ag/AgCl reference electrode. On the active surface, glucose
oxidase converts glucose to glucono-1,5-lactone and hydrogen
peroxide (H2 O2 ), which is detected as an amperometric
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cocaine as a first drug) and separated by 1 free day. Iv catheters
in this experiment were flushed three times with saline between
recording sessions to prevent contamination of the injected
solutions.

over 2 min) to induce general anesthesia. Then, the rat was
disconnected from the potentiostat and the sensor was removed
for post-recording calibrations. Rats were then transcardially
perfused with room-temperature PBS (pH 7.4) followed by 10%
formalin. Brains were later sectioned on a cryostat to a thickness
of 30 µm. The location of the sensors was verified using the
stereotaxic atlas of Paxinos and Watson (Paxinos and Watson,
1997).

Temperature Data Analyses
Temperature responses were analyzed as absolute changes,
as changes relative to the immediate pre-injection baseline
values, and as NAc-Muscle and Skin-Muscle temperature
differentials (i.e., the difference between relative temperature
changes in the corresponding locations) and presented as mean
values ± standard error. Slow changes in both temperature and
locomotion were analyzed in 1-min quantification bins using an
analysis window of 10-min before and 60-min after each iv drug
injection. Rapid changes were analyzed in 10-s bins for 120-s
before and 900 s after each iv drug injection.
Since the brain and temporal muscle receive arterial blood
from the same common carotid artery and are equally exposed
to blood-delivered heat from the body, NAc-Muscle temperature
differentials show the source of heat production, providing
a measure of drug-induced metabolic brain activation. Skin
temperature is determined by the state of peripheral vessels,
but also depends on the temperature of arterial blood inflow.
Therefore, Skin-Muscle temperature differentials exclude the
latter contribution and serves as an accurate measure of
peripheral vascular tone (Kiyatkin, 2010).

Electrochemical Data Analyses
Electrochemical data were sampled at 1 Hz (i.e., mean current
over 1 s) using the PAL software (Version 1.5.0, Pinnacle
Technologies) and analyzed using two time resolutions. Slow
changes in electrochemical currents were analyzed with 1-min
quantification bins using an analysis window of 5 min before
and 60 min after each iv injection. Rapid current changes were
analyzed with 8-s bins for 30 s before and 720 s after the onset
of iv injections of MDPV and cocaine, respectively. Since the
baseline currents slightly varied in amplitude between individual
glucose electrodes, absolute current changes were transformed
into relative changes taking a basal value before each event
(30 s for slow and 8 s for rapid time-course analyses) as 0
nA. These current changes were then transformed into glucose
concentration (µM) based on sensor sensitivity determined
during pre-recording in vitro calibrations and adjusted by
the temperature coefficient (95.6%) determined in previous
analytical studies (Kiyatkin et al., 2013). The data were also
presented as a percent change based on previously determined
basal levels of glucose in the NAc (range of 540–700 µM;
(Kiyatkin and Lenoir, 2012; Wakabayashi and Kiyatkin, 2015a;
Wakabayashi et al., 2015). These values are close to previous
electrochemical and microdialysis estimates conducted in awake
animals (0.4–0.7 mM; (Fellows et al., 1992; Lowry et al., 1994;
McNay and Gold, 1999), but lower than data obtained in
anesthetized rats (Silver and Erecinska, 1998).

Statistical Analyses
Statistical data analyses included the use of One-Way repeated
measure (RM) ANOVAs to find time periods where there was
a significant post-injection main effect and individual bins
were compared with respect to baseline using a Fisher posthoc test. The latency of the glucose response was determined
based on the first data point significantly different from baseline
(p < 0.05). Two-Way ANOVAs and other appropriate tests
were used to compare the effects of MDPV and cocaine. We
used area under the curve (AUC) for the period of drug
effect to fully capture the combined, overall effect of MDPV
and cocaine, as well as each response following repeated, insession drug injections. To examine the relationships between
individual temperature and neurochemical parameters we also
used correlation and regression analyses. For clarity, major
quantitative results of statistical comparisons are presented in
figure captions.

Experiment II
Surgical Preparations
In Experiment II, rats underwent the three-point thermocouple
electrode implantation procedure described in detail elsewhere
(Kiyatkin et al., 2015). Briefly, under general anesthesia, we
implanted miniature copper-constantan thermocouple probes
(125 µm in diameter) in the nucleus accumbens (NAc) shell
(AP +1.2 mm; L 0.9 mm; DV 7.2–7.4 mm), deep temporal
muscle, and subcutaneously along the nasal ridge with the tip
approximately 15 mm anterior to bregma. Testing cages were
light- and sound-attenuated and equipped with an electrical
swivel and a flexible cable that attached to the implanted
thermoelectrodes during recording sessions. Temperature data
were continuously recorded at a 10-s resolution using Thermes16 (Physitemp Instruments).

Results
General Pattern of Fluctuations in NAc Glucose
Induced by MDPV: Comparison with Cocaine
Initially we combined all MDPV-induced glucose responses
independent of their injection number within the session
and analyzed them at a 1-min resolution for 60 min postinjection (Figure 1). In contrast to a weak, not-significant
increase followed by a slow decrease below baseline detected
by glucose-null sensors (blue line), currents detected by the
glucose sensors (red line) rapidly decreased after the MDPV
injection, but began to rebound from ∼5 min post-injection

Protocol
The experimental protocol was identical to that in Experiment I,
except for one difference: each rat was exposed to both MDPV
and cocaine in two separate sessions. These sessions were strictly
counterbalanced (four with MDPV as a first drug and four with
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a strong, bimodal increase in glucose (∼60 µM, peak ∼14 min)
for ∼45 min post-injection [F(27,1620) = 15.35, p < 0.001;
Figure 1B). As such, MDPV and cocaine induce opposite
changes in NAc glucose [Two-Way ANOVA: main effect
F(1,56) = 7.21, Drug × Time interaction F(60,3360) = 10.73;
both p < 0.001], which differ in both the latency and
duration. However, both MDPV and cocaine similarly increased
locomotion for ∼40 min post-injection, with no between-drug
differences within the entire analysis interval (Figure 1C).

NAc Glucose Responses following Repeated
Injections of MDPV: Comparison with Cocaine
Next, we analyzed the NAc glucose and locomotor responses
induced by each of the four repeated MDPV injections
(Figure 2). While the initial injection of MDPV induced
a modest down-up change in NAc glucose (Figure 2A),
subsequent injections resulted in modest decreases in glucose
for ∼10 min post-injection (Figures 2B–D). However, total
response assessed by AUC for 45 min post-injection was minimal
with no significant differences between MDPV injections
(Figure 2I). This stability of MDPV-induced glucose responses
contrasted to progressive decreases in NAc glucose responses
occurring during repeated cocaine injections (Figures 2A–D).
However, locomotor responses remained relatively stable across
repeated injections of both MDPV and cocaine, with no
significant differences in amplitude, duration, and the AUC
(Figures 2E–H,J).
Since the maximal between-drug differences in glucose
dynamics were found within several minutes following
injections, next our data were analyzed at a high time resolution
(8-s bin) (Figure 3). In contrast to cocaine, which induced
ultra-fast glucose rise within the first 60 s after each drug
injection, MDPV within this time interval showed only weak,
non-significant glucose increases (Figures 3A–E). These initial
MDPV-induced increases were equally weak with each injection
but the initial rises induced by cocaine decreased across repeated
injections. However, MDPV induced a more prominent tonic
decrease in NAc glucose within 60–720 s post-injection; this
change remained relatively stable in amplitude, duration, and
AUC (Figures 3A–D,F). Within this time window, cocaine
induced greatest increases in NAc glucose during the first
injection and this change rapidly became weaker such that the
fourth response resembled that of MDPV. In this case, changes in
glucose levels induced by both drugs tightly correlated (r = 0.97;
see inset in Figure 3E).

FIGURE 1 | Overall changes in NAc [glucose] induced by intravenous
MDPV and cocaine. (A), the mean (±SEM) change in currents recorded by
glucose (red) and glucose-null (blue) sensors shown in 1-min bins from 5 min
before to 60 min after MDPV injections. (B), the mean ± SEM changes in NAc
[glucose] induced by MDPV and cocaine. (C), the overall locomotor response
to MDPV (green) and cocaine (black line). n, the number of drug injections and
number of rats averaged for this analyses. Filled symbols in (B) show values
significantly different from baseline (p < 0.05; Fisher post-hoc test after
significant drug effect detected by One-Way RM ANOVA). Asterisk in
(B) denotes the interval where there were significant differences between
drugs detected by a Fisher post-hoc test after significant main effects of drug
and Drug x Time interactions were found by Two-Way RM ANOVA.

General Pattern of Temperature Responses
Induced by MDPV and Cocaine
As shown in Figure 4, MDPV and cocaine induced similar
temperature responses: NAc and muscle temperatures
modestly increased for ∼40 min, while skin temperature
rapidly decreased, slowly returning to baseline at ∼30–40 min
(Figures 4A–D). Brain and muscle temperature increases
evaluated by AUC for 45-min post-injection were slightly
higher for MDPV than cocaine, but the difference was not
significant. However, decreases in skin temperature induced

exceeding the values detected by null sensor (Figure 1A). By
subtracting values detected by glucose and glucose-null sensors,
we found that glucose levels modestly but significantly decreased
(∼25 µM, nadir ∼4 min) and then rebounded to levels slightly
higher than the pre-injection baseline from ∼20 min postinjection [F(31,1740) = 5.51, p < 0.001; Figure 1B]. These
changes contrasted to those induced by cocaine, which elicited
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FIGURE 2 | Relative changes in NAc [glucose] and locomotion induced by MDPV and cocaine injections (1–4) assessed at low temporal resolution
(1-min bins). (A–D), The mean (±SEM) change in NAc [glucose] (µM) induced by MDPV (red circles) and cocaine (gray circles) for 60 min post-injection. (E–H),
changes in locomotor activity (mean ± SEM; counts/min). Vertical hatched lines (at 0 min) marked the onset of 20-s injections of MDPV and cocaine. Horizontal dotted
lines show basal levels (=0 µM). Concentration changes for the 60 min analysis window were significant for each MDPV [One-Way RM ANOVA, F(7, 420) = 2.63, 1.78,
1.48, and 3.54, all p < 0.05, respectively] and cocaine injection [F(6, 360) = 7.07, 3.63, 2.30, and 5.61]. Individual values significantly different from baseline (p < 0.05
Fisher test) are shown as filled symbols. MDPV induced significant locomotor activation after each injection [F(11, 671) = 2.06, 3.05, 3.80, 2.59 for injections 1–4,
respectively; p < 0.05, for clarity post-hoc test results not shown]. Right panels (I,J) show mean ± SEM values of glucose and locomotor responses induced by
MDPV and cocaine as assessed by the area under the curve for 45 min post-injection. Two-Way RM ANOVA analysis revealed a main effect of drug [F(1, 39) = 11.09,
p < 0.05] and Injection [F(3, 39) = 3.28, p < 0.05] on NAc glucose. Interaction was not significant. Asterisks show significant between-drug differences. The effect of
injection number on glucose response alone was not significant for both MDPV and cocaine (One-Way RM ANOVA). Overall locomotor responses during this time
period showed no significant differences between drugs or injection numbers. Original cocaine data were previously reported in detail (Wakabayashi and Kiyatkin,
2015a) and shown here for comparison.

much steeper, sharper drop in Skin-Muscle differential than
MDPV.
Although both drugs induced locomotor activation, a
noticeable difference was found during high-resolution analysis
(Figure 5C). While MDPV-induced locomotor activation
developed with a ∼120-s latency, cocaine induced a sharp spike
in motor activity during and immediately after the injection
(∼15 s).

by MDPV were significantly weaker than that for cocaine
(Figure 4E).
Both drugs also similarly increased NAc-Muscle differentials
and decreased Skin-Muscle differentials, suggesting metabolic
brain activation coupled with skin vasoconstriction, respectively
(Figures 4F,G). The increases in NAc-Muscle differentials were
very similar for both drugs, but the decrease in Skin-Muscle
differential for MDPV was weaker than that for cocaine;
the difference approached statistical significance (p = 0.057)
(Figure 4H). Both drugs also stimulated locomotion, with a
sharper and shorter response for cocaine (Figures 4I,J), but the
overall response was similar for both drugs (Figures 4I–K).
When analyzed at a high time-resolution (10-s bins),
MDPV displayed more rapid and stronger effects on NAc
temperatures than cocaine [Time × Drug interaction
F(49,1519) = 4.12, p < 0.05 (Figure 5A)]. Cocaine-induced
NAc increase became significant at ∼45 s, whereas MDPVinduced NAc increase became significant at 75 s from injection
onset. The difference between curves became significantly
different at ∼140 s (see asterisk in Figure 5A). Both drugs
had virtually identical effects on NAc-Muscle differentials,
but the increase induced by cocaine had shorter rapid onset
latency (15 vs. 45 s). Cocaine also displayed a significantly
stronger effect on the Skin-Muscle differential [Drug
F(1,31) = 4.32, Drug × Time interaction F(49,1519) = 1.77;
both p < 0.05] (Figure 5B). The difference between
curves became significant at ∼50 s, and cocaine showed a
Frontiers in Neuroscience | www.frontiersin.org

Temperature and Locomotor Effects of MDPV
and Cocaine following Repeated Drug Injections
When analyzed with respect to injection number, MDPVinduced increases in NAc temperature became larger with each
subsequent injection (Figures 6B,C). This effect was evident
with respect to response magnitude but the increase in the
AUC did not reach statistical significance. Despite this apparent
sensitization, both NAc-Muscle and Skin-Muscle differentials
remained relatively constant for each subsequent injection
(Figures 6E–G). A significant increase in locomotor activity
[Figures 6I,J; F(3,21) = 3.15, p < 0.05] was also detected across
injections.
Cocaine, on the other hand, showed a significant attenuation
in NAc temperature responses across injections [F(3,21) = 6.25,
p < 0.05; Figures 6A,C]. In addition, while NAc-Muscle
differentials remained relatively constant, the decrease in SkinMuscle differential attenuated over time [F(3,21) = 4.07, p <
0.05; Figures 6D,F,G]. Locomotor activity likewise significantly
6

September 2015 | Volume 9 | Article 324

Wakabayashi et al.

Cocaine-like and -unlike effects of MDPV

decreased during repeated cocaine injections [F(3,21) = 4.42,
p < 0.05] (Figures 6H,J).

The Relationships between Individual
Neurochemical and Temperature Parameters
Since changes in [glucose] are determined by changes in
metabolic activity and vessel tone, next we examined the
relationships between drug-induced glucose responses, NAcMuscle and Skin-Muscle differentials, two indices that reflect
intra-brain heat accumulation due to metabolic activation and
the state of skin vessels, respectively; the analysis window in this
case was defined from the moment of drug injection (0 s) to the
peak effect of MDPV on NAc glucose (360 s) (Figure 7).
When analyzed for MDPV, we found an exceptionally
strong correlation between changes in glucose and SkinMuscle differentials (Figure 7A; r = 0.99, p < 0.001),
suggesting that the decrease in glucose could be related to
drug-induced vasoconstriction. Additionally, as changes in SkinMuscle differentials tightly correlate with changes in NAc-Muscle
differentials (r = −0.99), MDPV-induced glucose decreases
also showed a strong negative correlation with NAc-Muscle
differentials (Figure 7B; r = −0.98). A slightly weaker, but also
significant negative correlation was also found between glucose
decrease and locomotor activity (Figure 7C; r = −0.84; p <
0.001).
When the same regression analysis was conducted for
cocaine for the same time window, no clear correlation was
apparent for all analyzed parameters. Both NAc-Muscle and
Skin-Muscle differentials showed complex non-linear changes.
For example, glucose levels strongly increased immediately after
cocaine injection, but Skin-Muscle and NAc-Muscle differentials
remained unaffected (see open circles for initial post-injection
data points in Figures 7D,E). Locomotor activity similarly
increased following a ∼20-s delay, despite the rapid rise in NAc
glucose (Figure 7F).
FIGURE 3 | Relative changes in NAc [glucose] induced by MDPV and
cocaine injections (1–4) assessed at high temporal resolution (8-s
bins). (A–D), mean (±SEM) changes in NAc [glucose] (µM) induced by MDPV
(red circles) and cocaine (gray circles) for 720 s after the injection onset.
Vertical shaded area (starting at 0 s) marked the onset of 20-s MDPV injection.
Horizontal dotted lines show basal levels (=0 µM). Concentration changes for
the 720 s analysis were significant for 2–4 injections of MDPV [F(7, 630) = 4.05,
3.73, 4.31, all p < 0.05] and 1–3 injections of cocaine [F(6, 534) = 3.24, 1.83,
4.19, all p < 0.05]. Individual concentration values significantly different from
baseline (Fisher test) are shown as filled symbols. (E,F), mean ± SEM values
of glucose responses induced by MDPV and cocaine as assessed by the area
under the curve for 60 s post-injection (E) and between 60 s and 720 s
post-injection (F). Two-Way RM ANOVA analysis revealed a main effect of drug
[F(1, 39) = 13.9, p < 0.05] on NAc Glucose during 60 s post-injection. Neither
Injection nor Interaction was significant. A similar analysis for the 60–720 s
interval revealed a main effect of drug and injection [F(1, 39) = 28.63,
F(3, 39) = 5.39, both p < 0.05). Interaction approached significance
[F(3, 39) = 2.73 p = 0.057]. Asterisks show significant between-drug
differences. The effect of injection number alone was not significant for MDPVor cocaine-induced [glucose] at this time interval (One-Way RM ANOVA). Inset
in (E) shows the correlation between the mean [glucose] response for the first
180 s after cocaine and MDPV injections (r = 0.98). Original cocaine data were
previously reported in detail (Wakabayashi and Kiyatkin, 2015a) and shown
here for comparison.
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Discussion
MDPV is a relatively new synthetic psychoactive drug of
abuse and many issues regarding its mechanisms of action
and physiological effects remain unknown. Based on its high
affinity to the monoamine transporters and known similarity
in stimulatory and sympathoexcitatory effects, MDPV is usually
viewed as a more active cocaine-like drug. This study combined
glucose electrochemistry, behavioral and temperature analyses
to determine whether MDPV does in fact mimic the effects
of cocaine and can accurately be described as “cocainelike.” Here we show that iv MDPV and cocaine used at
optimal self-administering doses similarly stimulate locomotion
and moderately increase brain and body temperatures due
to metabolic brain activation and peripheral vasoconstriction.
Although there were minor between-drug differences in
temperature and locomotor responses, MDPV and cocaine
had startlingly opposite effects on NAc glucose, an important
physiological parameter critical for the metabolic activity of brain
cells.
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FIGURE 4 | Overall changes in temperature and locomotion induced by iv MDPV and cocaine. (A,B), mean ± SEM changes in absolute temperature
recorded from the NAc, temporal muscle and skin. (C,D), relative temperature changes in the same locations. (F,G), changes in NAc-Muscle and Skin-Muscle
temperature differentials. (I,J), overall changes in locomotion. Data were obtained from eight rats (32 injections of each drug). Right panels show between-drug
differences in the effects on brain temperature (E), NAc-Muscle and Skin-Muscle differentials (H), and locomotion (K) as assessed by the area under the curve for
45 min post-injection. Asterisk shows significant between drug differences for skin temperature (p < 0.05).

Mechanisms Regulating Brain Glucose Levels

Kiyatkin and Wakabayashi, 2015) suggest that glucose entry into
the brain extracellular space is governed by two different and
simultaneously acting mechanisms. First, brain glucose levels
could increase following robust increases in blood glucose levels.

Previous studies (Fellows et al., 1992; Silver and Erecinska,
1994; Attwell et al., 2010), including our recent work with
electrochemical glucose monitoring (Kiyatkin and Lenoir, 2012;

Frontiers in Neuroscience | www.frontiersin.org
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levels are transiently lowered (Kiyatkin and Lenoir, 2012). Taking
into account structural specificity, this mechanism allows for the
redistribution of blood flow and thus delivery of oxygen and
glucose to areas of high metabolic demand. Therefore, via neural
regulation of local blood flow, the brain under physiological
conditions is able to prevent any possible glucose deficit and
anticipate future metabolic demands.

Cocaine-like and Cocaine-unlike Effects of MDPV
If local vasodilation induced by neuronal activation is responsible
for glucose entry into the extracellular space, it is reasonable
to infer that constriction of the cerebral vessels will have the
opposite effect. We found an exceptionally high correlation
(r = 0.99) between MDPV-induced changes in NAc glucose
and Skin-Muscle differential, a valid measure of vascular tone
(Figure 7A). This suggests that constriction evident in the skin
vessels also occurs in cerebral vessels within the NAc and
may be responsible for the drug-induced decrease in glucose
levels. Cocaine, however, induces a sharp rise in NAc glucose
immediately after injection, despite inducing arguably stronger
vasoconstriction. The next logical question that follows is: what
is the cause of this sharp, unexpected difference?
Unlike MDPV, cocaine induces a very strong, but transient
spike in motor activity immediately upon injection (see
Figure 5C). This effect is distinct and masked in the slower,
more tonic rise in locomotion that is similar for both MDPV
and cocaine. Our previous studies in awake rats revealed that
this ultra-fast motor effect of cocaine coincides with cortical
EEG desynchronization, EMG activation (Kiyatkin and Smirnov,
2010), and phasic excitation of ventral striatal neurons (Kiyatkin
and Brown, 2007). Therefore, the rapid rise in NAc glucose
induced by iv cocaine could reflect local vasodilation and local
increases in cerebral blood flow resulting from the activation of
accumbal neurons, despite systemic vasoconstriction.
Therefore, the difference in glucose response between MDPV
and cocaine could be primarily related to the unique properties
of cocaine, particularly its ability to directly interact with ionic
channels on afferents of sensory nerves (Lee et al., 2005) densely
innervating blood vessels (Göder et al., 1993; Michaelis et al.,
1994). Due to this action in the periphery and involvement of
sensory pathways, iv delivered cocaine is able to induce phasic
neural activation well before the drug reaches the brain and
interact with centrally located neural substrates. This hypothesis
was recently confirmed using cocaine-methiodide, a cocaine
analog that cannot cross the blood-brain barrier (Shriver and
Long, 1971; Hemby et al., 1994; Wise et al., 2008) but mimicked
the initial rapid and strong effects of cocaine by engaging
the same ionic channels in the afferents of peripheral sensory
nerves. Similar to cocaine, cocaine-methiodide rapidly induced
equally EEG desynchronization and EMG activation (Kiyatkin
and Smirnov, 2010), phasically excited ventral striatal neurons
(Kiyatkin and Brown, 2007), modestly increased brain and
muscle temperatures (Kiyatkin and Brown, 2007), and lastly
induced a virtually identical rapid glucose rise in the NAc
(Wakabayashi and Kiyatkin, 2015a). Despite its inability to cross
the blood-brain barrier, this drug induced skin vasoconstriction
to levels comparable to cocaine, confirming previous findings

FIGURE 5 | High-resolution analysis of changes in temperature and
locomotion induced by MDPV and cocaine. (A), mean ± SEM changes in
NAc temperature. Two-Way RM ANOVA revealed a significant of Time
[F(49, 1519) = 80.05, p < 0.001] and Drug × Time Interaction
[F(49, 1519) = 4.12] with no effect of Drug [F(1, 31) = 3.16, p = 0.08]. Small
arrow with asterisk shows the moment (∼160 s) when two curves significantly
diverge from each other. (B) shows mean ± SEM changes in NAc-Muscle and
Skin-Muscle differentials. Two-Way RM ANOVA revealed a main effect of Drug
[F(1, 31) = 4.32, p < 0.05], Time [F(49, 1519) = 54.45, p < 0.01], and Drug ×
Time Interaction [F(49, 1519) = 1.77, p < 0.01] on Skin-Muscle differential, with
no significant changes for NAc-Muscle differential. (C), mean ± SEM changes
in locomotion. The between-drug difference for locomotion was significant
only for 210 s after the injection onset [Drug × Time interaction
F(22, 682) = 1.57, p = 0.047]. Filled symbols in each graph show values
significantly different from baseline revaluated by One-Way RM ANOVA.

While such effects occur after high-dose glucose injections and
consumption of high glucose-containing products (Wakabayashi
and Kiyatkin, 2015b; Wakabayashi et al., 2015), blood glucose
levels are tightly regulated and remained relatively stable
under physiological conditions. Second, glucose entry could
also be rapidly increased or decreased via local vasodilation
or vasoconstriction that, respectively, enhances or diminishes
local cerebral blood flow. This mechanism of active entry is
neural activity-regulated, and thus is structure-specific (Attwell
et al., 2010; Mergenthaler et al., 2013). For instance, in the
NAc, arousing stimuli phasically excite most neurons and glucose
levels rapidly rise. In the substantia nigra pars reticulata, however,
most neurons are phasically inhibited by such stimuli and glucose
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FIGURE 6 | Relative changes in NAc temperature (A,B), NAc-Muscle and Skin-Muscle differentials (D,E) and locomotion (H,I) induced by MDPV and
cocaine injections (1–4). All parameters are shown with 1-min time resolution for 60 min post-injection. Right panels (C,F,G,J) shows differences in the effects of
each drug depending upon injection number and evaluated as the area under the curve (AUC) for 45 min post-injection. For cocaine, One-Way RM ANOVA revealed
significant effect on injection number on NAc temperature [F(3, 21) = 6.25, p < 0.05], Skin-Muscle differential [F(3, 21) = 4.07, p < 0.05] and locomotion [F(3, 21) = 4.42,
p < 0.05]. For MDPV, the effect was significant only for locomotion [F(3, 21) = 3.15, p < 0.05].

on the central mediation of this peripheral effect (Knuepfer and
Branch, 1992).
Although vasoconstriction induced by iv cocaine appears to be
triggered primarily via its action on peripheral neural substrates
(Knuepfer and Branch, 1992), the mechanisms underlying the
slightly weaker, but still significant peripheral vasoconstriction
induced by iv MDPV remain less clear. This effect is too
rapid to reflect a direct action of this drug on centrallylocated monoamine transporters. Possibly, MDPV interacts with
peripherally located dopamine and norepinephrine transporters
or has a direct, still undiscovered, direct action on adrenoceptors

Frontiers in Neuroscience | www.frontiersin.org

that controls vessel tone. Further experiments are necessary to
clarify this issue.
In contrast to MDPV-induced glucose responses, which
remained relatively stable with a tendency to increase across
repeated injections, cocaine-induced glucose responses became
weaker with each subsequent drug injection. MDPV-induced
increases in NAc temperature and locomotion also remained
relatively constant, while cocaine-induced increases in these
parameters became weaker across injections. This apparent
tolerance to cocaine is in contrast to the known sensitization
of locomotor and temperature responses of cocaine seen with
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FIGURE 7 | Correlative relationships between changes in NAc glucose, temperature parameters and locomotion. Pearson correlation coefficients and
linear regression were calculated for all animals in all experimental sessions using mean, high-resolution (10-s bins) data and an analysis window of 360-s
post-injection. Unfilled points labeled 1–5 represent the first five time points (-10 to 30 s) and correspond with effect latency. (A–C) show highly significant (p < 0.0001)
and tight correlations between MDPV-induced changes in NAc [glucose] and (A) Skin-Muscle differential (r = 0.99, y = 0.028x - 0.104), (B) NAc-Muscle differential (r
= −0.98, y = −0.007x + 0.025), and (C) locomotion (−0.84, y = −0.185x + 1.959). Data for cocaine is organized in parallel, with (D–F) displaying cocaine-induced
NAc [glucose] changes vs. the same three parameters described above. R-values and linear regression are not shown for cocaine because of absence of correlation.
Open circles with numbers are values for initial five time points (50 s) post-injection.

decreases cerebral blood flow (Du et al., 2009; Perles-Barbacaru
et al., 2012). These results may differ due to brain structure
specificity, varying drug doses, and routes of administration.
However, in our view, the major factor in this discrepancy
could be the use of general anesthesia, which is accompanied
by peripheral vasodilation. In contrast to the awake state, the
physiological effects of cocaine during anesthesia are drastically
different at multiple levels, including motor and EEG activity,
muscular tone, brain, body and skin temperatures, blood pressure
response, etc. . . (Kiyatkin and Smirnov, 2010). While iv cocaine
still desynchronized cortical activity when used during urethane
anesthesia, this effect was dramatically inhibited and slowed
(Kiyatkin and Smirnov, 2010), despite the known modest effects
of this general anesthetic on transmission of sensory signals.
Therefore, the neural effects of cocaine and local vascular and

repeated day-to-day administration (Post et al., 1987; Kalivas
et al., 1992; Blech-Hermoni and Kiyatkin, 2004), but is in
concordance with the known tolerance of cardio-vascular effects
of cocaine (Tella et al., 1999; Wilson et al., 2000). As such,
sensory mechanisms involved in mediating the neural effects of
cocaine may also hypothetically explain this difference. Similarly
to cocaine, neural and temperature responses elicited by natural
arousing stimuli also show progressive habituation following
repeated exposure (Kiyatkin et al., 2002).
While local neural activation and local vasodilation (or
increase in local cerebral blood flow) induced by cocaine is
supported by multiple pieces of evidence obtained via different
techniques (Stein and Fuller, 1993; Schmidt et al., 2006; Ceolin
et al., 2007; Howell et al., 2010; Pan et al., 2014), other studies
suggest that cocaine induces constriction of cerebral vessels and
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robust hyperthermia and lethality (Ross et al., 2012; Kesha et al.,
2013; Froberg et al., 2014). Although MDPV mimics the basic
psychoactive effects of cocaine, it is at least 10-fold stronger and
taking MDPV in place of cocaine may result in overdose or
unexpectedly strong autonomic and psychoactive effects. Due
to vasoconstriction coupled with local anesthetic action and
sympathetic activation, cocaine appears to be more dangerous
for the cardiovascular system than for the brain, where cocaine
is able to induce neural activity-regulated vasodilation, thus
increasing cerebral blood flow and delivery of glucose and oxygen
to the brain. In contrast, MDPV may be more hazardous to the
brain due to uncompensated cerebral vasoconstriction. In this
respect, MDPV resembles METH, which has the potential to
induce prolonged cerebral vasoconstriction and relative hypoxia
that contributes to acute health complications following drug
overdose (Polesskaya et al., 2011; Weaver et al., 2014).

blood flow responses as seen in anesthetized animal preparations
could be quite different from those recorded from the active brain
of animals and humans.

Functional Implications
In contrast to MDPV, cocaine elicits a rapid peripherally triggered
sensory signal, evidenced by the immediate post-injection surge
in NAc glucose, the faster onset of temperature effects, and the
initial, ultra-fast spike in motor activation. This interoceptive
signal (i.e., sensory cue) induced by cocaine results in earlier and
more direct reward signaling, which could be very important for
the acquisition of drug-taking behaviors (see Wise and Kiyatkin,
2011 for review). As such, in the initial stages of recreational
experimentation, cocaine users may be much more susceptible
to a transition into addiction than MDPV-users. The presumed
lack of primary sensory effects could also explain the high
association of MDPV use with environmental (exteroceptive)
stimuli. As MDPV is typically used by young adults under specific
drug-taking environments such as parties (“raves”), intense
sensory stimulation could act as conditioned, drug-associated
environmental cues, which could be especially important during
the transition from initial MDPV experimentation to chronic
abuse. Although recent work suggests that rats readily acquire
iv MDPV self-administration (Watterson et al., 2014; Aarde
et al., 2015), the data regarding the development of MDPV selfadministration vs. cocaine are absent and human evidence for
intravenous MDPV-use is currently very limited.
Finally, similar to other psychomotor stimulants, MDPV has
the potential to induce serious health complications, including
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